HYAMS, D.; BYUN, J.; MARTIN, B.; BAILEY, C.; STUMPF, T.; PETKOV, V. Combining the 31-gene expression profile test for cutaneous melanoma with the American Joint Committee on Cancer staging identifies the highest-risk patients with stage I-II disease. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 7, n. 4, p. s223, 2023. DOI: 10.25251/skin.7.supp.223. Disponível em: https://jofskin.org/index.php/skin/article/view/2198. Acesso em: 22 jul. 2024.